128 related articles for article (PubMed ID: 12621008)
1. Initial experience with oral contrast in PET/CT: phantom and clinical studies.
Cohade C; Osman M; Nakamoto Y; Marshall LT; Links JM; Fishman EK; Wahl RL
J Nucl Med; 2003 Mar; 44(3):412-6. PubMed ID: 12621008
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.
Otero HJ; Yap JT; Patak MA; Erturk SM; Israel DA; Johnston CJ; Sakellis C; Rybicki FJ; Van den Abbeele AD; Ros PR
AJR Am J Roentgenol; 2009 Aug; 193(2):326-32. PubMed ID: 19620427
[TBL] [Abstract][Full Text] [Related]
3. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.
Nehmeh SA; Erdi YE; Kalaigian H; Kolbert KS; Pan T; Yeung H; Squire O; Sinha A; Larson SM; Humm JL
J Nucl Med; 2003 Dec; 44(12):1940-4. PubMed ID: 14660720
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging.
Antoch G; Jentzen W; Freudenberg LS; Stattaus J; Mueller SP; Debatin JF; Bockisch A
Invest Radiol; 2003 Dec; 38(12):784-9. PubMed ID: 14627896
[TBL] [Abstract][Full Text] [Related]
5. Application of oral contrast media in coregistered positron emission tomography-CT.
Dizendorf EV; Treyer V; Von Schulthess GK; Hany TF
AJR Am J Roentgenol; 2002 Aug; 179(2):477-81. PubMed ID: 12130457
[TBL] [Abstract][Full Text] [Related]
6. Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies.
Nakamoto Y; Chin BB; Kraitchman DL; Lawler LP; Marshall LT; Wahl RL
Radiology; 2003 Jun; 227(3):817-24. PubMed ID: 12773683
[TBL] [Abstract][Full Text] [Related]
7. Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials.
Antoch G; Freudenberg LS; Stattaus J; Jentzen W; Mueller SP; Debatin JF; Bockisch A
AJR Am J Roentgenol; 2002 Dec; 179(6):1555-60. PubMed ID: 12438054
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
Sun XG; Huang G; Liu JJ; Wan LR
Hell J Nucl Med; 2009; 12(2):115-8. PubMed ID: 19675862
[TBL] [Abstract][Full Text] [Related]
9. Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation.
Antoch G; Kuehl H; Kanja J; Lauenstein TC; Schneemann H; Hauth E; Jentzen W; Beyer T; Goehde SC; Debatin JF
Radiology; 2004 Mar; 230(3):879-85. PubMed ID: 14764889
[TBL] [Abstract][Full Text] [Related]
10. Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT.
Büther F; Stegger L; Dawood M; Range F; Schäfers M; Fischbach R; Wichter T; Schober O; Schäfers KP
J Nucl Med; 2007 Jul; 48(7):1060-8. PubMed ID: 17574981
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
12. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
Beyer T; Bockisch A; Kühl H; Martinez MJ
J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
[TBL] [Abstract][Full Text] [Related]
13. [Basic and clinical studies of oral barium sulfate preparations for CT].
Higashi T; Taoka Y; Harada M; Nishitani H
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 May; 57(6):314-8. PubMed ID: 9194360
[TBL] [Abstract][Full Text] [Related]
14. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
Beyer T; Antoch G; Bockisch A; Stattaus J
J Nucl Med; 2005 Mar; 46(3):429-35. PubMed ID: 15750155
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
Mawlawi O; Erasmus JJ; Munden RF; Pan T; Knight AE; Macapinlac HA; Podoloff DA; Chasen M
AJR Am J Roentgenol; 2006 Feb; 186(2):308-19. PubMed ID: 16423932
[TBL] [Abstract][Full Text] [Related]
16. Oral contrast medium in PET/CT: should you or shouldn't you?
Groves AM; Kayani I; Dickson JC; Townsend C; Croasdale I; Syed R; Nagabushan N; Hain SF; Ell PJ; Bomanji JB
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1160-6. PubMed ID: 15937685
[TBL] [Abstract][Full Text] [Related]
17. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.
Antoch G; Freudenberg LS; Egelhof T; Stattaus J; Jentzen W; Debatin JF; Bockisch A
J Nucl Med; 2002 Oct; 43(10):1339-42. PubMed ID: 12368372
[TBL] [Abstract][Full Text] [Related]
18. Metallic artifacts caused by dental metal prostheses on PET images: a PET/CT phantom study using different PET/CT scanners.
Shimamoto H; Kakimoto N; Fujino K; Hamada S; Shimosegawa E; Murakami S; Furukawa S; Hatazawa J
Ann Nucl Med; 2009 Jul; 23(5):443-9. PubMed ID: 19399580
[TBL] [Abstract][Full Text] [Related]
19. [The effect of different chemoembolization materials on CT-based attenuation correction in PET/CT].
Heusner TA; Fronz U; Jentzen W; Verhagen R; Forsting M; Bockisch A; Antoch G
Rofo; 2007 Nov; 179(11):1159-65. PubMed ID: 17926254
[TBL] [Abstract][Full Text] [Related]
20. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
